Click for best price
Viral Conjunctivitis Drugs Market Size, Share 2022
Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely to exhibit a thumping CAGR of 69.60% between 2020 and 2023 and reach an opportunity worth US$462.4 mn by the end of the forecast period.
This report contains market size and forecasts of Viral Conjunctivitis Drugs in Global, including the following market information:
Global Viral Conjunctivitis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Viral Conjunctivitis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
FST-100 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viral Conjunctivitis Drugs include Adenovir Pharma, Allergan, NanoViricides, Takeda, NovaBay Pharmaceuticals, Novartis, Panoptes Pharma and NicOx, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Conjunctivitis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Conjunctivitis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Viral Conjunctivitis Drugs Market Segment Percentages, by Type, 2021 (%)
FST-100
APD-209
Global Viral Conjunctivitis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Viral Conjunctivitis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
ASCs
Others
Global Viral Conjunctivitis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Viral Conjunctivitis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Conjunctivitis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Viral Conjunctivitis Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adenovir Pharma
Allergan
NanoViricides
Takeda
NovaBay Pharmaceuticals
Novartis
Panoptes Pharma
NicOx
| Report Attributes |
Report Details |
| Report Title |
Viral Conjunctivitis Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Viral Conjunctivitis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Conjunctivitis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Conjunctivitis Drugs Overall Market Size
2.1 Global Viral Conjunctivitis Drugs Market Size: 2021 VS 2028
2.2 Global Viral Conjunctivitis Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Conjunctivitis Drugs Players in Global Market
3.2 Top Global Viral Conjunctivitis Drugs Companies Ranked by Revenue
3.3 Global Viral Conjunctivitis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Viral Conjunctivitis Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Viral Conjunctivitis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Conjunctivitis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Viral Conjunctivitis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Conjunctivitis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Viral Conjunctivitis Drugs Market Size Markets, 2021 & 2028
4.1.2 FST-100
4.1.3 APD-209
4.2 By Type - Global Viral Conjunctivitis Drugs Revenue & Forecasts
4.2.1 By Type - Global Viral Conjunctivitis Drugs Revenue, 2017-2022
4.2.2 By Type - Global Viral Conjunctivitis Drugs Revenue, 2023-2028
4.2.3 By Type - Global Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Conjunctivitis Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 ASCs
5.1.4 Others
5.2 By Application - Global Viral Conjunctivitis Drugs Revenue & Forecasts
5.2.1 By Application - Global Viral Conjunctivitis Drugs Revenue, 2017-2022
5.2.2 By Application - Global Viral Conjunctivitis Drugs Revenue, 2023-2028
5.2.3 By Application - Global Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Viral Conjunctivitis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Viral Conjunctivitis Drugs Revenue & Forecasts
6.2.1 By Region - Global Viral Conjunctivitis Drugs Revenue, 2017-2022
6.2.2 By Region - Global Viral Conjunctivitis Drugs Revenue, 2023-2028
6.2.3 By Region - Global Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Viral Conjunctivitis Drugs Revenue, 2017-2028
6.3.2 US Viral Conjunctivitis Drugs Market Size, 2017-2028
6.3.3 Canada Viral Conjunctivitis Drugs Market Size, 2017-2028
6.3.4 Mexico Viral Conjunctivitis Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Viral Conjunctivitis Drugs Revenue, 2017-2028
6.4.2 Germany Viral Conjunctivitis Drugs Market Size, 2017-2028
6.4.3 France Viral Conjunctivitis Drugs Market Size, 2017-2028
6.4.4 U.K. Viral Conjunctivitis Drugs Market Size, 2017-2028
6.4.5 Italy Viral Conjunctivitis Drugs Market Size, 2017-2028
6.4.6 Russia Viral Conjunctivitis Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Viral Conjunctivitis Drugs Market Size, 2017-2028
6.4.8 Benelux Viral Conjunctivitis Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Viral Conjunctivitis Drugs Revenue, 2017-2028
6.5.2 China Viral Conjunctivitis Drugs Market Size, 2017-2028
6.5.3 Japan Viral Conjunctivitis Drugs Market Size, 2017-2028
6.5.4 South Korea Viral Conjunctivitis Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Viral Conjunctivitis Drugs Market Size, 2017-2028
6.5.6 India Viral Conjunctivitis Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Viral Conjunctivitis Drugs Revenue, 2017-2028
6.6.2 Brazil Viral Conjunctivitis Drugs Market Size, 2017-2028
6.6.3 Argentina Viral Conjunctivitis Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Conjunctivitis Drugs Revenue, 2017-2028
6.7.2 Turkey Viral Conjunctivitis Drugs Market Size, 2017-2028
6.7.3 Israel Viral Conjunctivitis Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Viral Conjunctivitis Drugs Market Size, 2017-2028
6.7.5 UAE Viral Conjunctivitis Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Adenovir Pharma
7.1.1 Adenovir Pharma Corporate Summary
7.1.2 Adenovir Pharma Business Overview
7.1.3 Adenovir Pharma Viral Conjunctivitis Drugs Major Product Offerings
7.1.4 Adenovir Pharma Viral Conjunctivitis Drugs Revenue in Global Market (2017-2022)
7.1.5 Adenovir Pharma Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Viral Conjunctivitis Drugs Major Product Offerings
7.2.4 Allergan Viral Conjunctivitis Drugs Revenue in Global Market (2017-2022)
7.2.5 Allergan Key News
7.3 NanoViricides
7.3.1 NanoViricides Corporate Summary
7.3.2 NanoViricides Business Overview
7.3.3 NanoViricides Viral Conjunctivitis Drugs Major Product Offerings
7.3.4 NanoViricides Viral Conjunctivitis Drugs Revenue in Global Market (2017-2022)
7.3.5 NanoViricides Key News
7.4 Takeda
7.4.1 Takeda Corporate Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Viral Conjunctivitis Drugs Major Product Offerings
7.4.4 Takeda Viral Conjunctivitis Drugs Revenue in Global Market (2017-2022)
7.4.5 Takeda Key News
7.5 NovaBay Pharmaceuticals
7.5.1 NovaBay Pharmaceuticals Corporate Summary
7.5.2 NovaBay Pharmaceuticals Business Overview
7.5.3 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Major Product Offerings
7.5.4 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue in Global Market (2017-2022)
7.5.5 NovaBay Pharmaceuticals Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Viral Conjunctivitis Drugs Major Product Offerings
7.6.4 Novartis Viral Conjunctivitis Drugs Revenue in Global Market (2017-2022)
7.6.5 Novartis Key News
7.7 Panoptes Pharma
7.7.1 Panoptes Pharma Corporate Summary
7.7.2 Panoptes Pharma Business Overview
7.7.3 Panoptes Pharma Viral Conjunctivitis Drugs Major Product Offerings
7.7.4 Panoptes Pharma Viral Conjunctivitis Drugs Revenue in Global Market (2017-2022)
7.7.5 Panoptes Pharma Key News
7.8 NicOx
7.8.1 NicOx Corporate Summary
7.8.2 NicOx Business Overview
7.8.3 NicOx Viral Conjunctivitis Drugs Major Product Offerings
7.8.4 NicOx Viral Conjunctivitis Drugs Revenue in Global Market (2017-2022)
7.8.5 NicOx Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Viral Conjunctivitis Drugs Market Opportunities & Trends in Global Market
Table 2. Viral Conjunctivitis Drugs Market Drivers in Global Market
Table 3. Viral Conjunctivitis Drugs Market Restraints in Global Market
Table 4. Key Players of Viral Conjunctivitis Drugs in Global Market
Table 5. Top Viral Conjunctivitis Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Viral Conjunctivitis Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Viral Conjunctivitis Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Viral Conjunctivitis Drugs Product Type
Table 9. List of Global Tier 1 Viral Conjunctivitis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Conjunctivitis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Viral Conjunctivitis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Viral Conjunctivitis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Viral Conjunctivitis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Viral Conjunctivitis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Viral Conjunctivitis Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Viral Conjunctivitis Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Adenovir Pharma Corporate Summary
Table 31. Adenovir Pharma Viral Conjunctivitis Drugs Product Offerings
Table 32. Adenovir Pharma Viral Conjunctivitis Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Viral Conjunctivitis Drugs Product Offerings
Table 35. Allergan Viral Conjunctivitis Drugs Revenue (US$, Mn), (2017-2022)
Table 36. NanoViricides Corporate Summary
Table 37. NanoViricides Viral Conjunctivitis Drugs Product Offerings
Table 38. NanoViricides Viral Conjunctivitis Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Takeda Corporate Summary
Table 40. Takeda Viral Conjunctivitis Drugs Product Offerings
Table 41. Takeda Viral Conjunctivitis Drugs Revenue (US$, Mn), (2017-2022)
Table 42. NovaBay Pharmaceuticals Corporate Summary
Table 43. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product Offerings
Table 44. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Viral Conjunctivitis Drugs Product Offerings
Table 47. Novartis Viral Conjunctivitis Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Panoptes Pharma Corporate Summary
Table 49. Panoptes Pharma Viral Conjunctivitis Drugs Product Offerings
Table 50. Panoptes Pharma Viral Conjunctivitis Drugs Revenue (US$, Mn), (2017-2022)
Table 51. NicOx Corporate Summary
Table 52. NicOx Viral Conjunctivitis Drugs Product Offerings
Table 53. NicOx Viral Conjunctivitis Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Viral Conjunctivitis Drugs Segment by Type in 2021
Figure 2. Viral Conjunctivitis Drugs Segment by Application in 2021
Figure 3. Global Viral Conjunctivitis Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Viral Conjunctivitis Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Viral Conjunctivitis Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Viral Conjunctivitis Drugs Revenue in 2021
Figure 8. By Type - Global Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
Figure 12. US Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
Figure 24. China Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Viral Conjunctivitis Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Adenovir Pharma Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. NanoViricides Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takeda Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Panoptes Pharma Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. NicOx Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
